Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Cirrhosis 1Carcinoma, Hepatocellular 1

Interventions

lenvatinib 1Vitamin B 6 1Ultrasonography 1Tomography, X-Ray Computed 1Tidal Volume 1Radiomics 1Propranolol 1Portasystemic Shunt, Transjugular Intrahepatic 1Population Groups 1Plasmapheresis 1Nadolol 1Mebendazole 1Liquid Biopsy 1Injections 1Glutathione 1Gastroscopy 1Ferrosoferric Oxide 1Everolimus 1Dextrins 1Colonoscopy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Cirrhosis × Mebendazole × Clear all
NCT04443049 2021-10-05

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Institute of Liver and Biliary Sciences, India

Phase NA Unknown
170 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡